Home Categories Send inquiry

Posaconazole Intermediate POA CAS 149809-43-8 Factory High Quality

Factory Supply Posaconazole Related Intermediates, Commercial Production Posaconazole CAS 171228-49-2 Posaconazole Intermediate POA CAS 149809-43-8 Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate CAS 184177-81-9 1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine CAS 74853-08-0 2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxal CAS 170985-85-0 Diethyl L-(+)-Tartrate CAS 87-91-2
Name Posaconazole Intermediate POA
Synonyms (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester; (3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl p-Toluenesulfonate
CAS Number 149809-43-8
CAT Number RF-PI291
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C21H21F2N3O4S
Molecular Weight 449.47
Density 1.40
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical
Item Specifications
Appearance White to Grey White Powder
Identification IR In accordance with the standard
Melting Point 100.0-102.0℃
Specific Rotation [a]20/D -40.0° to -48° (C=1, CHCl3)
Loss on Drying ≤0.50%
Residue on Ignition ≤0.20%
Heavy Metals ≤20ppm
Related Substances
Major Impurity ≤0.40%
POA-Enantiomer ≤0.10%
POA-Diastereomer ≤0.20%
Individual Unknown Impurity ≤0.20%
Total Impurities ≤1.0%
Purity ≥99.0%
Assay 98.0%~102.0% (anhydrous substance)
Test Standard Enterprise Standard
Usage Intermediate of Posaconazole (CAS 171228-49-2)
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation. (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester (CAS 149809-43-8) is the Intermediate of Posaconazole (CAS 171228-49-2). Posaconazole is a triazole antifungal agent that blocks the synthesis of ergosterol by inhibiting of the enzyme lanosterol 14α-demethylase and accumulation of methylated sterol precursors, more potent at inhibiting 14α-demethylase than itraconazole.